Skip to main
GBT
GBT

Global Blood Therapeutics (GBT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GBT Stock

About Global Blood Therapeutics (GBT)

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in Febru...read more
Market cap$4.62B
Today's volume
Revenue (TTM)
Avg. daily volume3.42M
EBITDA (TTM)
Open
Price / earnings ratio-13.70x
Today's range
Debt / equity
52 week range$21.65 - $73.02
5 year debt / equity82.59x
Beta (LTM)1.03x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 8, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 25, 2025, the market cap for GBT stock is $4.63B

The current P/E ratio for GBT stock is -13.7

The 52-week high for GBT stock is $73.02. The current GBT stock price $undefined is 100.00% below its 52-week high

The 52-week low for GBT stock is $21.65. The current GBT stock price $undefined has increased 100.00% from its 52-week low

No, the GBT stock does not pay dividends to its shareholders

How to buy GBT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GBT stock

    Navigate to the Explore page. Then, type GBT into the search bar. When you see GBT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GBT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Global Blood Therapeutics Stock Earnings

The value each GBT share was expected to gain vs. the value that each GBT share actually gained.

GBT (GBT) reported Q2 2022 earnings per share (EPS) of -$1.26, missing estimates of -$1.18 by 6.78%. In the same quarter last year, GBT's earnings per share (EPS) was -$1.12. GBT is expected to release next earnings on 08/08/2022, with an earnings per share (EPS) estimate of $0.

Buy GBT Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.